Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection
A Phase III Trial to Promote Recovery From Covid 19 With Combined Doxycycline and Ivermectin Along Standard Care
Sponsor: Dhaka Medical College
Listed as NCT04523831, this PHASE3 trial focuses on Covid19 and remains completed. Sponsored by Dhaka Medical College, it has been updated 7 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Dec 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Dec 2021 [monthly]
Completed PHASE3
-
Nov 2020 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 2 earlier versions
-
Oct 2020 — Nov 2020 [monthly]
Completed PHASE3
Status: Recruiting → Completed
-
Sep 2020 — Oct 2020 [monthly]
Recruiting PHASE3
First recorded
Jun 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Dhaka Medical College
For direct contact, visit the study record on ClinicalTrials.gov .